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The antigen receptor for natural killer T cells (NKT
TCR) binds CD1d-restricted microbial and self-lipid
antigens, although the molecular basis of self-CD1d
recognition is unclear. Here, we have characterized
NKT TCR recognition of CD1d molecules loaded
with natural self-antigens (Ags) and report the
2.3 A˚ resolution structure of an autoreactive NKT
TCR-phosphatidylinositol-CD1d complex. NKT TCR
recognition of self- and foreign antigens was under-
pinned by a similar mode of germline-encoded
recognition of CD1d. However, NKT TCR autoreac-
tivity is mediated by unique sequences within the
non-germline-encoded CDR3b loop encoding for
a hydrophobic motif that promotes self-association
with CD1d. Accordingly, NKT cell autoreactivity
may arise from the inherent affinity of the interaction
between CD1d and the NKT TCR, resulting in the
recognition of a broad range of CD1d-restricted
self-antigens. This demonstrates that multiple self-
antigens can be recognized in a similar manner by
autoreactive NKT TCRs.
INTRODUCTION
Natural killer T (NKT) cells are innate-like T cells that recognize
lipid antigens presented by the nonpolymorphicmajor histocom-
patibility complex (MHC) class I-like molecule CD1d. NKT cells
express a highly restricted semi-invariant T cell receptor (NKT
TCR) repertoire. Upon stimulation, NKT cells rapidly produce
large amounts of cytokines and chemokines. In this manner,
NKT cells can modulate the response of other innate andadaptive immune cells, such as T and B cells, NK cells, and
dendritic cells (DCs). Consistent with this, NKT cells have been
shown to influence the outcome of immune responses in a broad
range of diseases, including cancer, autoimmunity, inflamma-
tion, and infection (Bendelac et al., 2007; Kronenberg, 2005;
Matsuda et al., 2008).
NKT TCRs are typically composed of an invariant TCRa chain
formed by a canonical rearrangement between the Va14 and
Ja18 gene segments in mice or their orthologs Va24 and Ja18
in humans (Dellabona et al., 1994; Lantz and Bendelac, 1994).
This TCRa chain associates with TCRb chains limited in their
Vb usage (Vb11 in humans and Vb8s, Vb7, and Vb2 in mice)
but with extensive junctional diversity in their complementary
determining region 3 (CDR3b) (Matsuda et al., 2001).
NKT cells can recognize CD1d molecules bound to a number
of different glycolipids. Because some of these glycolipids are
microbial in origin, it is thought that NKT cells contribute to
responses to invading bacteria. However, NKT cells also react
with CD1d-expressing antigen presenting cells (APCs) in the
absence of infectious organisms, suggesting that NKT TCRs
can recognize CD1d plus endogenous lipids and thus play
a role in autoimmunity or indirectly play a role in innate response
to infections. Several studies have investigated the nature of the
endogenous lipid antigen(s) presented by CD1d molecules in
various immunological contexts. More than 170 lipid species,
comprising glycerophospholipids and sphingolipids, have been
identified from human CD1d monomers produced by the human
B cell line 721.221 (Cox et al., 2009). Another study revealed that
phosphatidylcholine, lysophospholipids, and sphingomyelin
represent the main lipids associated with human CD1d mole-
cules expressed in this cell line (Yuan et al., 2009). Several
glycosphingolipids, including GM1a, GD1a, and GM2, are also
found bound by mouse CD1d expressed by myeloid APCs
(Muindi et al., 2010). Finally, various molecular species of phos-
phatidylcholine with different fatty acid compositions are found
loaded into mouse CD1d molecules produced by insect cellsImmunity 34, 315–326, March 25, 2011 ª2011 Elsevier Inc. 315
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Figure 1. TCR CDR3b Loop Modulates a-GalCer-
CD1d Tetramer Binding
(A) Staining of hybridomas expressing the Va14 TCRa
chain paired with the Vb8.2 chain in the context of the indi-
cated CDR3b-Jb rearrangement. The mean fluorescence
intensity (MFI) of a-GalCer-CD1d tetramer staining was
determined for a narrow TCR gate. Data represent the
mean + standard error of the mean (SEM) of two indepen-
dent experiments.
(B and C) Staining of hybridomas expressing the Va14i
TCRa chain paired withwild-type or CDR3b alanine substi-
tutions of the DN32.D3 (B) or 24.8.A (C) TCRb chains. The
MFI of a-GalCer-CD1d tetramer staining was determined
for a narrow TCR gate and is normalized to wild-type
MFI (set as 100%). Data represent the mean + SEM of
two independent experiments.
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Basis of NKT TCR Autoreactivity(Giabbai et al., 2005). These studies reveal the great diversity of
self-lipids that can be found associated with CD1d molecules
when produced in different systems.
The structures of several mouse and human NKT TCRs in
complex with CD1d bound to the marine sponge-derived
antigen a-galactosylceramide (a-GalCer) (Borg et al., 2007; Pel-
licci et al., 2009), a-GalCer analogs (Wun et al., 2011, this issue),
or relatedmicrobial glycolipids (Li et al., 2010) have recently been
solved. These structures show that NKT TCRs, regardless of
their precise TCRb sequence, dock similarly on CD1d. The loca-
tion and details of the docking are quite different from those seen
in the engagement of conventional TCRs to their MHC plus
peptide ligands (Godfrey et al., 2008). A ‘‘hot spot’’ on the NKT
TCR, composed only of germline-encoded residues, is essential
for recognition of CD1d plus several structurally diverse anti-
gens, including isoglobotrihexosylceramide (iGb3), which has
been proposed to be one of the self-antigens responsible for
NKT cell autoreactivity (Zhou et al., 2004). These studies also
suggest that the diverse CDR3b loop can modulate and fine
tune the interaction of NKT TCRs with CD1d-glycolipid antigen
complexes (Mallevaey et al., 2009). Presently, although the
structural basis of NKT TCR-CD1d-a-GalCer recognition is es-
tablished, it is unclear how the NKT TCR can recognize more
diverse CD1d-restricted ligands including CD1d-presenting
self-antigens during autoreactivity, which underpins NKT cell
activation in autoimmunity and cancer.
Self-recognition by NKT cells is an important issue (Gapin,
2010). It is involved in positive selection of NKT cell precursors
in the thymus (Bendelac et al., 2007) but is also implicated in
many diseases including cancer (Bellone et al., 2010; Swann
et al., 2007, 2009), ischemia-reperfusion injury, sickle cell
disease (Lappas et al., 2006; Wallace et al., 2009), and innate
responses to infection (Brigl and Brenner, 2010; Brigl et al.,
2003; Mattner et al., 2005; Paget et al., 2007). Although the
mechanisms underlying this ‘‘self-reactivity’’ are clearly an
important issue, so far they remain poorly defined. The problem
is difficult to investigate with the normal range of NKT TCRs
because they have, on the whole, relatively low affinity for their
endogenous ligands. To improve our ability to study NKT TCRs
reaction with self, we isolated NKT TCRs that have high affinity
for self-ligands. With this approach, via functional and structural
analyses, we showed that NKT TCR reactivity against a panel of
CD1d-self-lipid complexes is caused via the CDR3b loop directly
mediating contacts with the monomorphic CD1d molecule,316 Immunity 34, 315–326, March 25, 2011 ª2011 Elsevier Inc.whereas the self-antigen exclusively contacted the invariant
a chain. These results provide a molecular basis for under-
standing NKT cell autoreactivity and suggest that a range of
different CD1d-restricted self-lipids can be recognized in a
similar manner by the NKT TCR.
RESULTS
NKT TCR CDR3b Loop Modulates a-GalCer-CD1d
Tetramer Binding
Previous mutational data suggest that the hypervariable CDR3b
loop of NKT TCRs modulates the NKT TCR affinity for CD1d-
antigen complexes (Mallevaey et al., 2009; Scott-Browne et al.,
2007), although the basis for this is unclear. To further assess
the role of the CDR3b loop, we chose to clone four different
Vb8.2 chains with various CDR3b-Jb rearrangements derived
from NKT hybridomas 2C12 (Brossay et al., 1998a), DN32.D3
(Lantz and Bendelac, 1994), and 24.8.A (Gumperz et al., 2000)
and the Vb8.2 DO-11.10 TCRb chain that we used previously
(Scott-Browne et al., 2007). We expressed each TCRb chain
separately in the TCR-negative 5KC hybridoma together with
the invariant Va14-Ja18 chain. After gating for identical amounts
of TCR expression, all four hybridomas stained with a-GalCer-
CD1d tetramer with various intensities, with DO-11.10 and 2C12
being the highest, DN32.D3 moderate, and 24.8.A the weakest
(Figure 1A). Only minor variations on a-GalCer-CD1d tetramer
binding were detected in a previous alanine scanning of the
DO-11.10 CDR3b loop (Scott-Browne et al., 2007). Therefore,
we also substituted individual residues in the CDR3b of
DN32.D3 and 24.8.A with alanine and repeated the analysis with
each mutant chain expressed together with the wild-type Va14
chain. For DN32.D3, the bD94A, bD96A, bI97A, and bQ98A
substitutions had a minor or no effect on tetramer binding when
compared to the wild-type TCR, whereas the bG93A and bP95A
mutants enhanced interaction with the tetramer and the bN99A
almost completely abolished staining (Figure 1B). For 24.8.A,
the bD94A, bG96A, and bQ97A substitutions had little effect on
tetramer binding (Figure 1C), whereas the bG93A, bW95A, and
bD98A residue substitutions greatly enhanced tetramer staining
up to 3- to 4-fold, demonstrating that the wild-type 24.8.A
CDR3b is less than optimal for a-GalCer-CD1d recognition.
Together, these data demonstrate that amino acid composition
of the hypervariable CDR3b loop can positively or negatively
modulate NKT TCR recognition of the a-GalCer-CD1d complex.
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Figure 2. CDR3b Loops and Self-CD1d Complex Recognition
(A) Strategy used to identify CDR3b sequences that allow or not for self-CD1d complex recognition.
(B) Staining of hybridomas expressing the Va14 TCRa chain paired with the indicated TCRb chain. Data are representative of three independent experiments.
(C) Enzyme-linked immunosorbent assay of interleukin-2 (IL-2) production by the indicated hybridomas in response to A20 cells transfected or not withmCD1d, in
the presence of 10 mg/ml 1B1 antibody or isotype control. Data represent the mean + SEM of two independent experiments.
(D) Staining by self-CD1d tetramers and inhibition of IL-2 production by 1B1 antibody for the hybridomas expressing self-CD1d-reactive NKT TCRs. Control,
hybridoma expressing the Va14i TCRa chain paired with the Vb6 DO-11.10 TCRb chain.
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Basis of NKT TCR AutoreactivityCDR3b Loops Mediate Self-CD1d Complexes
Recognition
Next, we tested whether the CDR3b loop could also modulate
the affinity of the TCR for self-CD1d complexes. We have previ-
ously identified a population of cells, out of a library of hybrid-
omas expressing NKT TCRs with randomized CDR3b loops,
which could interact with CD1d tetramers prepared with re-combinant mouse CD1d protein monomers produced in
HEK293 human cell lines (Mallevaey et al., 2009). These CD1d
tetramers were presumably loaded with naturally expressed
self-antigen(s). To identify the nature of the CDR3b responsible
for this reactivity, we sorted self-CD1d tetramer-positive and
-negative cells and PCR amplified the TCRb chain (Figure 2A).
Each TCRb chain was sequenced and cloned into a retroviralImmunity 34, 315–326, March 25, 2011 ª2011 Elsevier Inc. 317
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Figure 3. NKT TCR Recognition of CD1d-PI
(A) Overview of the autoreactive 2A3-D NKT TCR-
CD1d-PI complex (left) compared to the Vb8.2
NKT TCR-CD1d-a-GalCer complex. Associated
footprints on CD1d are shown underneath and
highlight the greater role of the CDR3b loop
(gold) in the autoreactive complex.
(B) Interactions mediated via the CDR2b loop in
the 2A3-D NKT TCR-CD1d-PI complex.
(C)The twohydrophobic residues (Leu95,Leu96) in
CDR3b act as a hydrophobic capby shielding from
solvent a surface-exposed hydrophobic patch on
CD1d. Van der Waals (vdw) radii shown as dots.
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Basis of NKT TCR Autoreactivityvector and expressed separately with the invariant Va14 chain
into TCRab hybridomas. The cells were then stained with
the self- and a-GalCer-CD1d tetramers. All hybridomas bound
the a-GalCer-CD1d tetramer and 7 out of 17 hybridomas also
bound the CD1d tetramers loaded with natural self-antigen(s)
(Figure 2B). These results demonstrate that particular CDR3b
loop sequences can confer self-reactivity while retaining
a-GalCer reactivity. Sequence analysis of the CDR3b loops
expressed by the highly self-reactive TCRs (mean fluorescent
intensity [MFI] > 30) revealed the preferential usage of the hydro-
phobic residues leucine and/or isoleucine at the first and second
position of the CDR3b loop, whereas the sequences found
within the self-CD1d tetramer-negative cells appeared diverse
(Table S1 available online).318 Immunity 34, 315–326, March 25, 2011 ª2011 Elsevier Inc.Hybridomas expressing TCRs that
bound CD1d tetramers naturally loaded
with self-lipid(s) responded well to A20
cells transfected with CD1d. This reac-
tivity was inhibited by the addition of
anti-CD1d (Figure 2C). Interestingly, the
percentage of inhibition obtained by the
addition of anti-CD1d inversely corre-
lated to the relative avidity of each
TCR expressed by the hybridoma, as
measured by self-CD1d tetramer binding
(Figure 2D). By contrast, hybridomaswith
TCRs that did not bind CD1d tetramers
naturally loaded with self-lipid(s) were
not autoreactive. Altogether, these data
demonstrate that a hydrophobic stretch
of amino acids within the CDR3b loop of
a-GalCer-CD1d tetramer-positive NKT
TCRs can determine self-reactivity.
Crystal Structure of an NKT
TCR-Self-Antigen-CD1d Complex
To gain further insight as to how the
CDR3b loop controls the reactivity with
CD1d molecules naturally loaded with
self-antigen(s), we expressed and re-
folded the autoreactive NKT TCR 2A3-D
(Figure 2; Table S1), then formed and
crystallized the complex with mouse
CD1d molecules complexed to the self-antigen phosphatidylinositol (PI) (Table S2). The electron density
at the NKT TCR-CD1d interface was unambiguous (Figure S1),
thereby permitting detailed analysis into the structural basis of
autoreactivity by the 2A3-D NKT TCR. NKT TCR-CD1d contacts
are described below, whereas NKT TCR-PI contacts are detailed
later in ‘‘Self-Antigen Permissibility of the NKT TCR.’’
The NKT TCR docked in a parallel, tilted mode, directly above
the F0-pocket of CD1d, as observed previously in NKT TCR-a-
GalCer-CD1d complexes, thereby providing immediate insight
that the recognition of self-CD1d closely approximates the
recognition of nonself-CD1d-ligands (Figure 3A). Further, the
conformation of the CD1d Ag-binding clefts when bound to
the self-Ag and a-GalCer were very similar (not shown), indi-
cating that the autoreactivity was attributable to an inherent
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Figure 4. Mutational Analysis of the 2A3-D NKT TCR
Staining of hybridomas expressing mutant versions (horizontal axes) of the Va14i-2A3-Db TCRa (left) or TCRb (right) with mouse CD1d tetramers loaded with
naturally expressed self-antigens(s) (A) or a-GalCer (B). Dark blue, CDR1a; magenta, CDR2a; green, CDR3a; light blue, CDR1b; light pink, CDR2b; yellow,
CDR3b. WT, unsubstituted Va14i-2A3-Db TCR (wild-type controls); control, Va14i-Vb6-DOb TCR; ND, not done. The MFI of tetramer staining for each mutant
was determined for a narrow TCR gate and is normalized to wild-type MFI (set as 100%). Data represent the mean normalized MFI + SEM of at least two inde-
pendent experiments.
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Basis of NKT TCR Autoreactivityproperty within the 2A3-D NKT TCR. Within this docking frame-
work, the invariant CDR3a loop played a predominant role, inter-
acting with both CD1d a helices, whereas the Va14 chain made
a small contribution by contacting V72 and S76 of CD1d (Fig-
ure 3A; Table S3).
The 2A3-D NKT TCR was isolated from a library expressing
modified Vb6 chains in which the CDR2b loop had been replaced
with the corresponding sequence found in the Vb8.2 CDR2b
loop, such as to provide the appropriate contact residues
important for CD1d recognition (Mallevaey et al., 2009). The
two tyrosine residues (bY46 and bY48) of the modified CDR2b
loop converged on the same region of CD1d, with bY46 forming
H bonds with E83 and a salt bridge with K86, and bY48 sitting
againstM87 andH bonding to E83. Furthermore, bE54H bonded
to the main chain of CD1d and formed a salt bridge with K86
(Figure 3B; Table S3); collectively these interactions were
comparable to that previously observed in the Vb8.2 NKT TCR-
a-GalCer-CD1d complex. The buried surface area of the autor-
eactive NKT TCR CD1d-complex was 940 A˚2, compared to
that of 760 A˚2 of the Vb8.2 NKT TCR-CD1d complex. Notably,
whereas the CDR3b loop of the NKT TCR has previously been
shown to play at most a minor role in contacting CD1d, for the
2A3-D NKT TCR, it played a more prominent role, exclusively
interacting with CD1d, positioned away from the PI head group
(Figure 3A). Specifically, the dileucine motif at the tip of the
CDR3b loop made direct contacts with L145 and K148 of
CD1d. Further, these two leucine residues (bL95 and bL96)
appeared to act as a hydrophobic cap, sitting above, and subse-quently shielding from solvent, a hydrophobic region on CD1d,
that comprised A152, V149, the aliphatic moiety of K148, L145,
and M87 (Figure 3C). The hydrophobicity of this region was
also extended by bL95 directly contacting bY48, the latter of
which contacted M87 (Figure 3C).
Collectively, the structure showed that the hydrophobic nature
of the tip of the CDR3b loop played an important role in driving
NKT TCR autoreactivity by sequestering a surface-exposed,
hydrophobic region of the CD1d-Ag binding cleft.
Mutational Analysis of 2A3-D TCR
Next, alanine substitution was applied to each residue in the
CDR loops of the 2A3-D NKT TCR and each mutant was
analyzed with a tetramer-binding assay. As shown in Figure 4,
the effect of mutations in the three CDRs of the 2A3-D TCRa
chain to the binding of self-CD1d tetramers was very similar to
the pattern of reactivity of the NKT TCR with the DO11.10
TCRb chain interacting with the a-GalCer-CD1d complex
(Scott-Browne et al., 2007). The ‘‘hot spot,’’ composed of the
CDR1a, CDR3a, and CDR2b loops, was also important for the
recognition of the natural self-antigen(s)-CD1d complex, sug-
gesting that the mode of recognition of natural self-antigen(s)
by the NKT TCR is likely to be very similar to that of a-GalCer.
Interestingly, the bL95A and bL96A substitutions in the CDR3b
loop largely abrogated self-CD1d tetramer binding, indicating
that the hydrophobic interactions mediated via these residues
are critically important for the interaction. We also tested the
effect of these mutations on the binding to a-GalCer-CD1dImmunity 34, 315–326, March 25, 2011 ª2011 Elsevier Inc. 319
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Figure 5. Grafting of Autoreactive CDR3b Loop
Transfers Autoreactivity
Staining of hybridomas expressing the Va14 TCRa chain
paired with the indicated Vb chains in the context of the
2A3-D CDR3b.
(A) Representative dot plots of three independent experi-
ments.
(B) The MFI of a-GalCer-CD1d tetramer staining was
determined for a narrow TCR gate. Data represent the
mean + SEM of three independent experiments.
(C) Reactivity of the 2A3-DNKT TCRwith CD1dmolecules.
Staining of the 2A3-D hybridoma with tetramers made of
mouse CD1d monomers or mouse CD1d:Ig complexes,
produced in the indicated cell lines.
Data are representative of three independent experiments.
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Basis of NKT TCR Autoreactivitytetramers. Addition of a-GalCer in tetramer preparations greatly
enhanced staining intensities for all hybridomas. Only four resi-
dues, CDR3a D93 and R94 and CDR2b Y46 and Y48, were
essential to the recognition of the a-GalCer-CD1d complex,
thereby defining the ‘‘core’’ residues within the hot spot neces-
sary for interacting with the antigenic-CD1d complex. Interest-
ingly, whereas the two leucine residues (95 and 96) in the
CDR3b loop were important for recognition of the self-CD1d
tetramers, we detected only a 10% reduction in a-GalCer-
CD1d tetramer binding as compared to the wild-type counter-
part for the bL95A substitution and the bL96A substitution had
no effect. Thus, whereas the CDR3b loop is not critically impor-
tant for a-GalCer-CD1d recognition, the two hydrophobic
leucine residues at position b95 and b96 of the 2A3-D CDR3b
were critical to confer reactivity to CD1d molecules loaded
with natural self-lipids. The importance of this hydrophobic motif
for the recognition of self-CD1d was further supported by the
bL95I and bL95V mutations, which had either no effect or mild
effects on self-CD1d tetramer binding, respectively (see
Figure S2).
Grafting of Autoreactive CDR3b Loop Transfers
Autoreactivity
We cloned the Vb6, Vb7, Vb8.1, Vb8.2, and Vb8.3 chains sepa-
rately with the 2A3-D CDR3b loop to test whether it would be
sufficient to provide reactivity to self-CD1d molecules. 5KC
hybridoma containing the Va14 invariant chain were transduced
with each TCRb construct and tested for their interactionwith the
CD1d tetramers loaded with natural self-lipid(s) and a-GalCer-
CD1d tetramers. Importantly, in a similar analysis performed
with all mouse Vb chains containing the DO-11.10 CDR3b
loop, no reactivity to CD1d loaded with natural self-lipid(s) was
detected but NKT TCRs demonstrated a wide range of avidity
for CD1d-antigen complexes as a function of Vb usage, with
Vb8.2 displaying the highest relative avidity whereas others,320 Immunity 34, 315–326, March 25, 2011 ª2011 Elsevier Inc.such as Vb6, showed no interaction with
CD1d-antigen complexes (Mallevaey et al.,
2009). With this new CDR3b loop, however, all
NKT TCRs stained intensely with a-GalCer-
CD1d tetramers, and the Vb8.2-containing
NKT TCR now stained with self-CD1d tetramers
(Figure 5A). Interestingly, the hierarchy of rela-
tive avidity conferred by different Vb usagewithin the TCR (Vb8.2 > Vb8.1 R Vb7 > Vb8.3 > Vb6) was
conserved irrespective of the CDR3b loop used (Figure 5B). Alto-
gether, these results show that the 2A3-D CDR3b loop similarly
increases the overall affinity of the NKT TCR for the CD1d-
antigen complexes, including those comprised of self-antigens.
We next tested whether CD1d tetramers derived from either
human 293 cells, insect cells, or mouse B cell lymphoma
J558L (Schu¨mann et al., 2003) differed in their ability to bind
the 2A3-D TCR. 2A3-D hybridomas stained similarly in each
case (Figure 5C) and furthermore, similar staining was observed
when a-GalCer was added to the reagents. This important result
suggests that the 2A3-D TCR can interact with mouse CD1d
molecules loaded, perhaps with a variety of different self-lipid
(s) and certainly with self-lipids from a variety of cell sources.
Conserved Recognition of Self- and Exogenous
Antigens
To extend the idea that the 2A3-D CDR3b loop can confer
enhanced CD1d recognition independently of the antigen, we
first isolated a-GalCer-CD1d reactive and nonreactive hybrid-
omas from a CDR3b library of Vb6-expressing NKT TCR and
sequenced their TCRb chains (Mallevaey et al., 2009). The iso-
lated CDR3b sequences were then cloned into wild-type or
CDR2b-modified Vb6 chains (denoted as Vb6*) and transduced
into 5KC together with the Va14i chain (Figure 6). Staining inten-
sities for self-CD1d tetramers and a-GalCer-CD1d tetramers
were compared. As expected, Vb6-containing NKT TCRs
bearing a CDR3b sequence with hydrophobic residues at posi-
tion 1 and 2 (LFTPA) stained with a-GalCer-CD1d tetramer (Fig-
ure 6). By simply transferring this CDR3b loops into the Vb6*
chains, the resulting TCR could now interact with the self-
CD1d tetramers. An NKT TCR with a CDR3b sequence without
the hydrophobic residues at the beginning of the loop (SRSCY)
showed no interaction with self- or a-GalCer-CD1d tetramers
when this loop was expressed within wild-type Vb6 chain but
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Figure 6. Conserved Recognition of Self- and Exogenous Antigens
Staining of hybridomas expressing the Va14 TCRa chain paired with the indi-
cated TCRb chain. Data are representative of three independent experiments.
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Basis of NKT TCR Autoreactivitystained with a-GalCer-CD1d tetramer when the loop was ex-
pressed in the context of the Vb6* chain. The experiment was
repeated with other CDR3b loops derived from the two groups
with similar results (data not shown). These results suggest
that particular CDR3b loops can modulate the recognition by
the NKT TCR of CD1d molecules presenting either self- or exog-
enous lipid antigens similarly.
Self-Antigen Permissibility of the NKT TCR
What is the nature of the self-lipid(s) or glycolipid(s) that are being
recognized by the autoreactive NKT TCRs? To start addressing
this question, we generated 28 different CD1d tetramers inde-
pendently loaded with a panel of self-lipids that either have
been found associated with CD1d molecules (Cox et al., 2009;
Yuan et al., 2009) or have been identified in the mouse thymus
by mass spectrometry (Li et al., 2009). We also produced four
control tetramers with the same volume of solvent used to
solubilize the various lipids. These various tetramers were then
used to independently stain the hybridoma expressing the NKT
TCR composed of the Vb8.2 chain with the 2A3-D CDR3b loop(Figure 5). The choice of this particular TCR was dictated by its
slightly lower apparent avidity for the CD1d tetramer loaded
with natural self-lipids compared to the 2A3-D TCR (Figure 5A).
Addition of solvent alone to the mCD1d monomers before tetra-
merization did not hamper the capacity of the CD1d tetramers
loaded with natural self-lipid(s) to interact with the Vb8.2-
2A3-D NKT TCR (data not shown). Tetramers made with b-glu-
cosylceramide (b-GluCer), b-galactosylceramide (b-GalCer),
phosphatidylethanolamine (PE), phosphatidylcholine (PC), gan-
gliotriaosylceramide (asialo-GM2), tetrasialoganglioside GQ1b,
and all lysophospholipids also stained similarly to the tetramer
loaded with natural self-lipids (Figure 7A). However, addition of
iGb3, phosphatidylserine (PS), phosphatidylinositol (PI), or phos-
phatidic acid (PA) to the tetramers led to an increase of tetramer
binding for a similar level of TCR expression (Figure 7A). In
contrast, addition of b-lactosylceramide (b-LacCer), sulfatide,
globotrihexosylceramide (Gb3), globoside (Gb4), monosialogan-
gliosides GM1, GM2, GM3, GM4, disialogangliosides GD1a,
GD1b, GD3, or trisialoganglioside GT1b reduced, sometimes
back to background values, the binding to the NKT TCR (Fig-
ure 7A). These results show that not all potential self-antigens
are recognized by these high-affinity NKT TCRs and further
demonstrate that several structurally distinct self-lipids can be
recognized by the NKT TCR.
To gain insight as to how some self-antigens might prevent
recognition by the autoreactive TCR, we analyzed the structure
of CD1d-sulfatide (Zajonc et al., 2005) and that of the 2.5 A˚
resolution structure of thebulky disialogangliosidesGD3 inbinary
complex with CD1d (Table S4). The autoreactive NKT TCR
complex was docked onto these nonpermissive CD1d-self-Ag
complexes, and both the sulfatide and GD3 self-antigens appear
incompatible with the conserved mode of NKT TCR recognition
(Figure S4). In both cases, the head groups obstructed the
incomingNKT TCRbecause of steric hindrancewith the invariant
a chain, thereby providing a plausible explanation to the lack of
tetramer binding to the autoreactive TCR (Figure 7A).
Given that the 2A3-D TCR recognized the PI self-antigen with
the highest avidity (Figure 7A), we determined, via surface
plasmon resonance (SPR), its affinity for the PI-CD1d and the
a-GalCer-CD1d complexes. These affinity measurements were
compared to that of another nonautoreactive Vb8.2 NKT TCR
(Pellicci et al., 2009). Interestingly, the 2A3-D TCR bound to
a-GalCer-CD1d with such high affinity that it would not readily
dissociate (Figure S3), indicating very low nM binding affinity,
whereas the affinity for the nonautoreactive Vb8.2 NKT TCR-
a-GalCer-CD1d interaction was 94 nM (Pellicci et al., 2009).
In contrast, the 2A3-D TCR bound to PI-CD1d with an affinity
of 3 mM (Figure 7B), whereas no appreciable binding was
observed for the Vb8.2 NKT TCR-PI-CD1d interaction (not
shown), indicating that the 2A3-D TCR had a higher propensity
to bind CD1d when compared to that of the Vb8.2 NKT TCR.
We subsequently analyzed the contacts between the 2A3-D
TCR and the PI self-antigen. As expected, the polar head group
of PI is exposed and is thus able to be directly contacted by the
NKT TCR. Comparison of the structures of the 2A3-D TCR-PI-
CD1d complex with the Va14-Vb8.2 NKT TCR-a-GalCer-CD1d
complex showed that the conformation of the CD1d or the
CDR loops of the respective NKT TCRs were very similar (Fig-
ure S5), indicating that there was no requirement for increasedImmunity 34, 315–326, March 25, 2011 ª2011 Elsevier Inc. 321
Figure 7. NKT TCR Recognition of CD1d-
Self-Ag
(A) Antigen permissiveness by the NKT TCR.
Staining of the hybridoma expressing the Va14-
Vb8.2 TCR containing the CDR3b of 2A3-D with
CD1d tetramers loaded with the indicated glyco-
lipids or phospholipids (x axes). The MFI of CD1d
tetramer staining was determined for a narrow
TCR gate. Red dotted line, MFI with CD1d
tetramer loaded with vehicle only (self-CD1d
tetramer); blue dotted line, MFI with no addition
of CD1d tetramer. Data represent the mean of
two independent experiments.
(B) Binding of the 2A3-D NKT TCR tomCD1d-PI as
assessed by SPR. NKT TCR were injected over
streptavidin-immobilized mCD1d-PI and over an
empty flow cell. Sensorgrams show the binding
(response units, RU) of decreasing concentrations
of TCR (22.5, 11.25, 5.625, 2.8125, 1.406 mM, 703,
351, 176, 87.9 43.9 nM) to the mCD1d-PI after
subtraction of the control flow cell. Insets show
saturation plots demonstrating equilibrium binding
of NKT TCR to immobilized CD1d-PI.
(C) Interactions between 2A3-D NKT TCR and PI.
(D) Interactions between Vb8.2 NKT TCR and
a-GalCer. Only the TCRa chain is depicted for
clarity.
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Basis of NKT TCR Autoreactivityplasticity of the NKT TCR to accommodate the bulkier head
group of PI. The PI head group is oriented such that the phos-
phate moiety abuts the CDR1a loop, whereas the inositol ring
sits underneath and contacts the CDR2a loop and extends into
bulk solvent, with the 30-OH and 40-OH groups being fully solvent
exposed (Figure 7C). Surprisingly, the PI head group does not
make any direct interactions with the Ja18-encoded CDR3a
loop, with its interactions being limited to a water-mediated
contact between the phosphate moiety and the CDR3a loop.
Instead, the phosphate moiety packs against P28 and forms
an H bond with N30 from the CDR1a loop. Only the 60- and
50-OH groups of the inositol ring are sequestered by the NKT322 Immunity 34, 315–326, March 25, 2011 ª2011 Elsevier Inc.TCR, with the 60-OH group H bonding to
N30a, whereas the 50-OH H bonds to
the main chain of the CDR2a loop and
further forms an H bond to K68, a frame-
work residue from the invariant a chain
(Figure 7C). Further, the conformation of
the inositol ring is stabilized by vdw inter-
actions between the CD1d a2 helix and
the CDR2a loop of the NKT TCR.
The plane of the inositol ring sits
approximately perpendicular to the
CD1d-Ag binding cleft in stark contrast
to themore parallel-packed conformation
of the galactosyl-head group of a-GalCer
(Figure 7D), revealing that the mode of
interactions between this self- and foreign
Ag differ markedly. The a-GalCer head
group sits directly underneath the
CDR1a loop and abuts the CDR3a loop,
with the 20-, 30-, and 40-OH groups being
sequestered closely by the NKT TCR, which contrasts that of
the inositol ring-mediated interactions. The only site of common-
ality between the PI- and a-GalCer-mediated interactions is
where 40-OH of a-GalCer approximates the position of the phos-
phate moiety of PI and thereby mimics the interactions with
Asn30a from the CDR1a loop.
Accordingly, there is a marked difference in the way in which
the invariant NKT TCRa chain directly contacts the PI self-Ag
when compared to the foreign a-GalCer agonist. Nevertheless,
by conserving the same dockingmode onto CD1d, the autoreac-
tive NKT TCR can accommodate the recognition of various
self- and nonself-antigens.
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The recognition of self-antigens presented by CD1d is an
intrinsic characteristic of NKT cells and relates both to the normal
functioning and aberrant activity of NKT cells. Our findings
provide a molecular basis for understanding NKT autoreactivity.
Here we show that a hydrophobic motif within the CDR3b
loop of the NKT TCR can modulate the affinity of the NKT
TCR for CD1d-self-antigen complexes. Notably, hybridomas en-
gineered to express NKT TCRs incorporating this CDR3b loop
were highly autoreactive to a variety of CD1d-expressing APCs
(data not shown). We have previously shown that, in general,
changes in the NKT TCRb chain affect the affinity of the TCR
for a ligand but do not affect the order of the hierarchy with which
this TCR reacts with different ligands (Mallevaey et al., 2009).
Therefore, the results presented here with the high-affinity
2A3-D TCR are representative of the relative abilities of other
NKT TCRs to react with different ligands. The results are thus
relevant to our understanding of the specificities of NKT TCRs
in general. The crystal structure of the autoreactive NKT TCR-
CD1d-PI complex demonstrates that this motif directly interacts
with CD1d, indicating that self-reactivity is not mediated via
Ag-specific contacts, because the CDR3b loop is positioned
distant from the self-antigen, in this case PI. This CDR3b
sequence acted as a hydrophobic cap sequestering an other-
wise surface-exposed hydrophobic patch on the a2 helix on
CD1d, thereby leading to an energetically favored association.
We suggest that many CDR3b sequences containing hydro-
phobic residues at these positions would favor NKT cell autor-
eactivity. However, the presence of such a hydrophobic cap is
probably not the only means by which the CDR3b loop can
increase the overall affinity of the NKT TCR for CD1d, because
no obvious correlation between CD1d binding affinity and
CDR3b loop sequences was observed in a recent report using
autoreactive human NKT TCRs (Matulis et al., 2010).
Previous data had suggested that differences of reactivity
between NKT cell hybridomas generated from different tissues
were the result of the presentation of different self-antigens by
CD1d expressed by different APCs (Brossay et al., 1998b;
Park et al., 1998). Our current data indicate that autoreactive
NKT cells might in fact be directed toward a set of self-antigens
common to many APC types and that antigen-independent
mechanisms might be responsible for the difference in observed
responses.
Parts of our study were conducted with NKT TCRs composed
of Vb6 chains in which the CDR2b loop had been replaced with
that of Vb8.2 (Mallevaey et al., 2009), and therefore it could be
argued that these chimeric TCRs might not be reflective of
‘‘native’’ NKT TCRs. Our mutational and structural analyses,
however, demonstrated that these NKT TCRs dock onto CD1d
in a manner essentially identical to what has been previously
reported for another NKT TCR with a Vb8.2 chain (Pellicci
et al., 2009). Thus, the gain of affinity of these TCRs for CD1d-
self-antigen molecules was mediated only by the increased
energy provided by the unique CDR3b loops. Furthermore,
transfer of these unique CDR3b loops into native Vb8.2 chains
was sufficient to generate NKT TCRs capable of interacting
with self-CD1d tetramer. Altogether, these results demonstrate
that recognition by these autoreactive TCRs reflects normalNKT TCR recognition and reinforce the idea that the NKT cell
repertoire is on a sliding scale of avidity, which is modulated
by the CDR2b and CDR3b loops (Mallevaey et al., 2009). Our
crystallographic data also reveal that the mode in which NKT
TCRs recognize foreign CD1d-restricted Ags mirrors that of
NKT TCR recognition of self, thereby further highlighting the
innate-style properties of the NKT TCR. Namely, the energetic
basis of NKT TCR recognition of both CD1d-a-GalCer and
CD1d-self-Ags was underpinned by the germline-encoded
CDR1a, CDR3a, and CDR2b loops. Recognition of ‘‘self’’ also
required the involvement of the CDR3b loop, although this loop
was dispensable for the recognition of a-GalCer, which can be
attributed to differences of energy provided to the interaction
by the different antigens, with the ‘‘self’’ antigens being of low
affinity. These results suggest that the natural TCR repertoire
of NKT cells is inherently reactive to, but has a suboptimal affinity
for, self-antigens. Notably, the region of the a2 helix of CD1d that
was contacted by the CDR3b loop of the NKT TCR has been
speculated to move depending upon the lipid tail lengths of
CD1d-restricted glycolipids (McCarthy et al., 2007). Therefore,
it is possible that different self-antigens might be able to
modulate the overall affinity of CD1d recognition through such
a mechanism.
Whereas the autoreactive NKT TCR recognized a broad panel
of self-lipids, it did not recognize certain lipids well. These find-
ings do not parallel a previous report regarding the isolation of
rare NKT cells specific for phospholipids (Gumperz et al., 2000).
Instead, the autoreactive NKT TCRs we described here were
not antigen specific and could accommodate the recognition of
several, but not all, self- and foreign glycolipids. It is possible
that certain lipids have to change conformation to enable NKT
TCR-CD1d ligation, as hasbeen recently observed for amicrobial
lipid (Li et al., 2010), whereas the more ‘‘bulky’’ or rigid antigens
hinder recognition. Because CD1d molecules at the surface of
APCs are most probably loaded with a variety of different self-
antigens (Cox et al., 2009; Muindi et al., 2010; Yuan et al.,
2009), our results suggest that autoreactivity of NKT cells might
derive from a shift in the balance between self-antigens that
canbe recognizedby theNKTTCRandself-antigens that cannot.
Different immune conditions might be able to alter this balance
through changes in APC type and activation status, Toll-like
receptor signaling (Brigl et al., 2003; Mattner et al., 2005; Paget
et al., 2007; Salio et al., 2007), CD1d expression (Sko¨ld et al.,
2005), or cytokine expression (Wesley et al., 2008).
The determination of the autoreactive NKT TCR-PI-CD1d-self-
complex provides compelling insight into how the NKT TCR can
accommodate ligands that aremarkedly structurally dissimilar to
that of a-GalCer or closely related Ags. In contrast to the close
sequestration of the galactosyl-headgroup by the NKT TCR,
the bulkier polar head group of PI is orientated toward the bulk
solvent. It is anticipated that the autoreactive NKT TCR will
recognize other self-ligands that are similar to PI (e.g., PC, PE,
PS, PA) in an analogous manner. Further, it is suggestive that
the b-linked self-glycosphingolipid Ag, iGb3, may adopt a similar
binding mode, with the three sugar moieties of iGb3 orientating
toward the a chain.
NKT cells expressing TCRs capable of interacting with CD1d
tetramer loaded with natural self-antigen(s) are not detected
directly ex vivo. This might be the result of several nonexclusiveImmunity 34, 315–326, March 25, 2011 ª2011 Elsevier Inc. 323
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Basis of NKT TCR Autoreactivitypossibilities. First, the affinity of the NKT TCR for ‘‘self’’ is much
lower than the affinity for a-GalCer (Cantu et al., 2003; Kjer-
Nielsen et al., 2006; Pellicci et al., 2009; Sidobre et al., 2004),
making it difficult to detect by direct tetramer staining. Second,
unique CDR3b sequences encoding for hydrophobic residues
in the middle of the loop were necessary for this reactivity. The
random generation of such CDR3b sequences by the recombi-
nation machinery is achieved only by nucleotide addition,
making the generation of such NKT TCRs an infrequent event.
Finally, it is possible that NKT precursor cells in the thymus
expressing TCRs with too high affinity for self-antigen(s) might
undergo negative selection that limits the generation of NKT cells
with high self-CD1d tetramer reactivity.
Altogether, we have demonstrated that NKT cell autoreactivity
can be the result of a hydrophobicmotif within the CDR3b loop of
the NKT TCR that mediates direct recognition with CD1d in an
antigen-independent manner. We also provide structural basis
of how an NKT TCR can recognize structurally distinct ligands.
Conceptually, our data represent a large step in our under-
standing of NKT-cell autoreactivity in general, including the
identification of a set of candidate self-antigens that can be
recognized by the autoreactive TCR. The next challenge will be
to determine which, and how, any of these self-antigen(s) plays
an active role in NKT cell biology.
EXPERIMENTAL PROCEDURES
Reagents
Mouse CD1d monomers, produced in HEK293 cells, were obtained from the
National Institutes of Health Tetramer Core Facility. Mouse CD1d monomers
produced in insect Hi5 cells were a generous gift fromM. Kronenberg (La Jolla
Institute for Allergy and Immunology). Mouse CD1d:Ig protein (Dimer X),
produced in the mouse B cell lymphoma J558L, was purchased from BD
Biosciences. a-galactosylceramide (a-GalCer), isoglobotrihexosylceramide
(iGb3), and globotrihexosylceramide (Gb3) were purchased from Alexis
Biochemicals. Phosphatidylinositol (PI), phosphatitic acid (PA), and lysophos-
pholipids were purchased from Avanti Polar Lipids. All other glycolipids and
phospholipids were purchased from Matreya, LLC.
TCRab Constructs and Retroviral Plasmids
Wild-type and mutant TCRa chains were generated as previously described
(Scott-Browne et al., 2007). TCRb constructs were cloned into mouse stem
cell virus-based plasmids with an internal ribosome entry site (IRES) plus
sequence encoding for the human nerve growth factor receptor as a reporter.
In some instances, DNA was purified from sorted hybridomas and TCRb
chains were cloned as described above. All TCR V-gene segments are named
and their amino acids are numbered according to the International Union of
Immunological Societies-Arden compilation (Arden et al., 1995). This system
of numbering is based on the known amino termini of several V-gene
segments. This numbering follows a system developed for immunoglobulin
V elements in which the V-framework residues are numbered consistently. In
this way, the cysteine residues that form the intrachain disulfide bond are
numbered consistently. The varying lengths of the V loops are dealt with by
consistent numbering of the most common length with omission of numbers
for shorter loops and the addition of lowercase letters to accommodate longer
loops.
Cell Lines and Retroviral Packaging
TCRa and b constructs were expressed by retroviral transduction of 5KCC3 or
5KC D8, two clones derived from the 5KC-78.3.20 TCRa- and TCRb-negative
hybridoma (White et al., 1993) that were selected for the loss of CD1d expres-
sion (not shown). Retroviral plasmids were transfected into Phoenix cells
together with the pCLEco accessory plasmid with Lipofectamine 2000 (Invitro-
gen) according to the manufacturer’s specifications. Retrovirus-containing324 Immunity 34, 315–326, March 25, 2011 ª2011 Elsevier Inc.supernatants were harvested 48 hr after transfection, centrifuged, and filtered
for removal of debris. Hybridomas were ‘‘spin-infected’’ at 33003 g for 90 min
at 37C in retrovirus-containing supernatants supplemented with polybrene
(8 mg/ml). Hybridomas were then sorted on a MoFlo cell sorter (Dakocytoma-
tion) on the basis of retroviral reporter and TCRb expression.
Tetramer Staining
Glycolipids and phospholipids were dissolved in various solvents as indicated
in Table S5 and diluted to working concentration in a vehicle solution (0.9%
NaCl 0.05% [vol/vol] Tween 20). Biotinylated recombinant mouse CD1d
proteins were incubated overnight with the indicated glycolipid or phospho-
lipid in vehicle solution and then tetramerized by the addition of phycoery-
thrin-conjugated streptavidin. Alternatively, the ‘‘self’’ tetramer was prepared
identically with the addition of vehicle only. Control tetramers were prepared
by the addition of the same volume of solvent in vehicle solution. Antigen
loading of mCD1d:Ig protein and preparation of mCD1d:Ig staining reagents
were performed according to the manufacturer’s specifications. Hybridomas
were stained for 45 min at 25C with the indicated tetramer plus antibody to
TCRb (anti-TCRb; H57-597; eBioscience). Cells were analyzed by flow cytom-
etry on FACScalibur (BD Biosciences) or LSR II (BD Biosciences) instruments
and data were analyzed in FlowJo (Treestar).
Hybridoma Stimulation
A total of 5 3 104 hybridomas were cultured for 20 hr with 5 3 104 A20 cells
transfected or not with mouse CD1d, in complete RPMI medium containing
10% (vol/vol) FCS, in the presence of 10 mg/ml anti-mCD1d (1B1; eBioscience)
or isotype control. Hybridoma responses were measured by an IL-2 enzyme-
linked immunosorbent assay in accordance with standard protocols.
Protein Production and Purification
Mouse CD1d (mCD1d) was produced as described previously (Matsuda et al.,
2000). In brief, mCD1d was made with the baculovirus pBacp10pH (provided
by M. Kronenberg, La Jolla Institute for Allergy and Immunology, CA, USA).
Recombinant mCD1d was produced with a BirA tag followed by a 6 histidine
tag, with the High Five insect cell line (Invitrogen). Soluble mCD1d protein was
purified with Ni-Agarose affinity purification followed by size exclusion through
a Superdex 200 16/60 gel filtration column. Soluble NKT TCR Va14 and 2A3-D
chains were expressed in E. coli strain BL21 and produced in inclusion bodies.
The inclusion body protein was harvested, refolded, and purified as described
by Garboczi et al. (1996), except for the addition of 5 M urea in the refolding
buffer.
Phosphatidylinositol Lipid Loading of mCD1d
mCD1d lipid loading was carried out by incubating mCD1d with a 3 molar
excess of GD3 overnight at room temperature. The loaded species was
subject to reloading with PI under the same conditions. After each loading
stage, anion exchange purifications were performed to separate loaded and
unloaded species.
Complex of 2A3-D NKT TCR with mCD1d
Purified NKT TCR and mCD1d-PI were mixed and incubated at room temper-
ature with gentle agitation for 45 min. The ternary complex (TCR, mCD1d-PI)
was separated from any TCR and mCD1d monomer by size exclusion through
a Superdex 200 16/60 column. Purified protein was then spin concentrated to
10 mg/ml.
Crystallization, Structure Determination, and Refinement
Hanging drop vapor diffusion crystallization experiments were performed by
mixing 1 ml of protein and 1 ml of mother liquor (13% polyethylene glycol
6000 and 0.1M sodium citrate [pH 6.1]). Crystals were cryoprotected by slowly
passing the crystal through mother liquor drops, sequentially increasing the
glycerol concentration to 15%. Diffraction data from the ternary complex
crystals were collected with synchrotron radiation and processed with Mosflm
(Table S2). With the NKT TCR Va14-Vb7-CD1d-a-GalCer structure (PDB
3HE7), with CDR loops, lipid, and waters removed, Phaser was able to yield
an interpretable 2.9 A˚ experimental map, revealing a single molecule in the
asymmetric unit as predicted from the Matthew’s coefficient. The model
was then rigid-body refined into the experimental map before careful model
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initial model for refinement of a higher 2.3 A˚ resolution data set. PI could be
easily placed in the unbiased difference density (Figure S1), which adopted
a single conformation. Iterative model building and refinement with
PHENIX (Zwart et al., 2008) yielded a final model with final statistics shown
in Table S2. The quality of the structure was assessed with programs within
the CCP4 suite. CD1d-GD3 was crystallized with crystallization conditions
similar to that used for other CD1d-binary structures (Zajonc et al., 2008)
and refined to 2.5 A˚ resolution (see Table S4).
Surface Plasmon Resonance Measurements and Analysis
All surface plasmon resonance (SPR) experiments were carried out at 25C on
a Biacore 3000 instrument with HBS buffer (10 mM HEPES-HCl [pH 7.4],
150 mM NaCl, and 0.005% surfactant P20 supplied by manufacturer).
Equilibrium affinity measurements of the NKT TCR-PI-CD1d and NKT TCR-
a-GalCer-CD1d interaction were determined by SPR and have been described
previously (Kjer-Nielsen et al., 2006), with the CD1d-PI being specifically
coupled to a SA sensor chip (GE Healthcare). The NKT TCR was passed
over the sensor chip at 5 mL/min for 150 s at 25C and the final response
was subtracted from that of an empty flow cell. All measurements were mini-
mally in duplicate, and the BIAevaluation Version 3.1 (Biacore AB) was used for
all data analysis.
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